The Bob Willis Fund

Posted: December 1 2021

The Impact of your money – Prostate Cancer UK

The Impact of your money – Prostate Cancer UK

The Bob Willis Fund’s live cricket event partner is Prostate Cancer UK. From the launch of our book ‘A Cricketer and A Gentleman,’ we have been giving money to support their important research into the earlier diagnosis of prostate cancer. We are delighted to continue our association and hear a little more about where some of the money has been spent.

Simon Grieveson, Head of Research at Prostate Cancer UK, said: “Prostate Cancer UK has a simple ambition – to stop prostate cancer damaging the lives of men and their families.

“We are proud to stand side by side with The Bob Willis Fund in the fight against prostate cancer, and we thank them for their tireless and passionate support of us. We are unified in wanting to change the game for men and their families, and this has seen them donate more than £200,000 to Prostate Cancer UK, helping us to fund pioneering research to transform the way prostate cancer is diagnosed and treated.

“These funds will support two exciting new projects aiming to combat the most common cancer in men.

“£150,000 has been granted to Dr Jennifer Munkley at Newcastle University, who is spearheading a Prostate Cancer UK project to develop a completely new way to diagnose prostate cancer.

Jennifer’s test detects a pattern of sugar molecules that is unique to prostate cancer cells. These sugars can be found in the blood, and early results have shown that this test can accurately differentiate between low-risk prostate cancer and cancer that needs urgent treatment. Whilst there’s still lots more work to be done, we’re really excited about these results and this test has real potential to be used as part of a national screening programme for prostate cancer in the future.

“The Bob Willis Fund have also granted £50,000 to Professor Daniel Brewer at the University of East Anglia, whose team is investigating the link between bacteria in the urine and aggressive prostate cancer. If successful, this research could be groundbreaking and would open up the possibility of using antibiotics to prevent or halt prostate cancer in its tracks.

“We are extremely grateful for the support of The Bob Willis Fund, and together we can deliver a future where lives are not limited by prostate cancer.”

For more information about the research go to:

« Back to news archive